Vaccine Type: Non Replicating Viral Vector
Developers: Serum Institute of India Private Limited, Indian Council of Medical Research (ICMR)
This vaccine is approved.
About Trial Phases
There are no trials for this phase.
This vaccine is the same formulation as the Oxford/AstraZeneca vaccine (AZD1222)
Total Enrollment: 1,600
© 2021 McGill COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form